Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+8.12%
adds when stocks drop
when a holding falls −10%+
Middle response
-3.27%
baseline attrition
Rally response
+0.00%
adds into rallies
when a holding rises +10%+
Top positions · 2
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | $23M | 89.3% | -11.0% | 4.5 yr |
| IPSCCentury Therapeutics, In | $3M | 10.7% | +374.8% | 2.0 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$26M
Country
GB89.3%-8.5pp
US10.7%+8.5pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| AUTL | $26M | -0.00B | -11.0% |
Top buys this quarter · 0
No buys this quarter
Top sells this quarter · 0
No sells this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26M | 2 | -2.52% | +17.59% | -20.11% | -0.00B |
| 2025-12-31 | $34M | 2 | -14.90% | +17.72% | -32.62% | +0.00B |
| 2025-09-30 | $28M | 2 | -55.61% | +17.52% | -73.12% | -0.00B |
| 2025-06-30 | $39M | 2 | -36.27% | +14.94% | -51.21% | +0.00B |
| 2025-03-31 | $26M | 2 | -76.22% | +8.30% | -84.52% | -0.01B |
| 2024-12-31 | $53M | 3 | -63.97% | +24.89% | -88.86% | +0.00B |
| 2024-09-30 | $81M | 3 | +54.22% | +36.04% | +18.18% | -0.01B |
| 2024-06-30 | $86M | 3 | +46.48% | +24.49% | +21.99% | +0.00B |
| 2024-03-31 | $150M | 2 | +246.74% | +29.62% | +217.12% | -0.01B |
| 2023-12-31 | $158M | 4 | +238.95% | +26.18% | +212.77% | -0.03B |
| 2023-09-30 | $67M | 4 | +8.88% | +21.57% | -12.69% | +0.00B |
| 2023-06-30 | $66M | 4 | -15.90% | +19.42% | -35.33% | -0.01B |
| 2023-03-31 | $62M | 4 | -55.88% | -7.82% | -48.06% | +0.00B |
| 2022-12-31 | $63M | 4 | -11.21% | +7.56% | -18.78% | +0.01B |
| 2022-09-30 | $58M | 4 | -24.38% | -4.93% | -19.45% | +0.00B |
| 2022-06-30 | $70M | 4 | -32.13% | -16.11% | -16.02% | -0.00B |